These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 2288531

  • 1. [Simvastatin (MK-733), a new HMG-CoA reductase inhibitor, in the treatment of hypercholesterolemia in elderly patients with atherosclerosis].
    Giannini SD, de Góes JM, Dereviack BE, Machado C, Forti N, Diament J.
    Arq Bras Cardiol; 1990 Jun; 54(6):407-14. PubMed ID: 2288531
    [Abstract] [Full Text] [Related]

  • 2. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study].
    Forti N, Ramires JA.
    Arq Bras Cardiol; 1991 Sep; 57(3):253-61. PubMed ID: 1824203
    [Abstract] [Full Text] [Related]

  • 3. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K, Sasaki J, Arakawa K.
    Clin Ther; 1989 Sep; 11(2):247-57. PubMed ID: 2736571
    [Abstract] [Full Text] [Related]

  • 4. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M, Sailer S, Irsigler H, Klein W, Patsch JR.
    Wien Med Wochenschr; 1995 Sep; 145(21):577-83. PubMed ID: 8560901
    [Abstract] [Full Text] [Related]

  • 5. Simvastatin treatment of hypercholesterolemia in patients with insulin dependent diabetes mellitus.
    Sartor G, Katzman P, Eizyk E, Kalén J, Nilsson A, Ugander L, Ursing D.
    Int J Clin Pharmacol Ther; 1995 Jan; 33(1):3-6. PubMed ID: 7711988
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J, Brun LD, Blank D, Campeau L, Crockford P, Curnew G, Dafoe W, Davignon J, Dufour R, Emery G.
    Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
    [Abstract] [Full Text] [Related]

  • 7. A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in Korean patients with hypercholesterolemia.
    Park S, Kang HJ, Rim SJ, Ha JW, Oh BH, Chung N, Cho SY.
    Clin Ther; 2005 Jul; 27(7):1074-82. PubMed ID: 16154486
    [Abstract] [Full Text] [Related]

  • 8. [Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study].
    Ghizzoni G, Rusconi C, Faggiano P, Sabatini T, Oneglia C, Gardini A.
    Minerva Cardioangiol; 1993 Mar; 41(3):105-9. PubMed ID: 8510811
    [Abstract] [Full Text] [Related]

  • 9. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide].
    Berioli S, Bentivoglio M, Conti R, Osanna RA, Savino K, Zollino L, Corea L.
    Cardiologia; 1990 Apr; 35(4):335-40. PubMed ID: 2245435
    [Abstract] [Full Text] [Related]

  • 10. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
    Bays HE, Ose L, Fraser N, Tribble DL, Quinto K, Reyes R, Johnson-Levonas AO, Sapre A, Donahue SR, Ezetimibe Study Group.
    Clin Ther; 2004 Nov; 26(11):1758-73. PubMed ID: 15639688
    [Abstract] [Full Text] [Related]

  • 11. [Therapy of hypercholesterolemia after heart transplantation with the HMG-CoA reductase inhibitor simvastatin in long-term follow-up].
    Wenke K, Thiery J, Meiser B, Arndtz N, Seidel D, Reichart B.
    Z Kardiol; 1995 Feb; 84(2):130-6. PubMed ID: 7717016
    [Abstract] [Full Text] [Related]

  • 12. [Effects and side effects of a 1-year treatment of primary hypercholesterolemia with simvastatin].
    Brocard JJ, Keller U, Oberhänsli A, Riesen WF.
    Schweiz Med Wochenschr; 1991 Jun 29; 121(26):977-83. PubMed ID: 1862314
    [Abstract] [Full Text] [Related]

  • 13. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 29; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 14. Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease.
    French JK, White HD, Greaves SC.
    N Z Med J; 1990 Feb 14; 103(883):41-3. PubMed ID: 2304688
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
    Lee SH, Chung N, Kwan J, Kim DI, Kim WH, Kim CJ, Kim HS, Park SH, Seo HS, Shin DG, Shin YW, Shim WJ, Ahn TH, Ho Yun K, Yoon MH, Cha KS, Choi SW, Han SW, Hyon MS.
    Clin Ther; 2007 Nov 14; 29(11):2365-73. PubMed ID: 18158077
    [Abstract] [Full Text] [Related]

  • 16. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L, Reyes R, Johnson-Levonas AO, Sapre A, Tribble DL, Musliner T.
    Clin Ther; 2007 Nov 14; 29(11):2419-32. PubMed ID: 18158082
    [Abstract] [Full Text] [Related]

  • 17. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun 14; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 18. [Effect of a long-term treatment with simvastatin, an inhibitor of HMG-CoA reductase, in dyslipidemic patients at high risk].
    Strano A, Novo S, Notarbartolo A, Davì G, Abrignani MG, Alaimo G, Averna MR, Barbagallo CM, Marino G.
    Cardiologia; 1989 Dec 14; 34(12):1027-33. PubMed ID: 2634479
    [Abstract] [Full Text] [Related]

  • 19. [Comparative effects of policosanol and two HMG-CoA reductase inhibitors on type II hypercholesterolemia].
    Prat H, Román O, Pino E.
    Rev Med Chil; 1999 Mar 14; 127(3):286-94. PubMed ID: 10436712
    [Abstract] [Full Text] [Related]

  • 20. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group.
    Lambert M, Lupien PJ, Gagné C, Lévy E, Blaichman S, Langlois S, Hayden M, Rose V, Clarke JT, Wolfe BM, Clarson C, Parsons H, Stephure DK, Potvin D, Lambert J.
    Pediatrics; 1996 May 14; 97(5):619-28. PubMed ID: 8628597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.